These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15915824)

  • 1. The ubiquitin-proteasome pathway: limitations and opportunities.
    Attaix D; Ventadour S; Taillandier D; Combaret L
    J Support Oncol; 2005; 3(3):221-2. PubMed ID: 15915824
    [No Abstract]   [Full Text] [Related]  

  • 2. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.
    Tisdale MJ
    J Support Oncol; 2005; 3(3):209-17. PubMed ID: 15915823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of muscle atrophy.
    McKinnell IW; Rudnicki MA
    Cell; 2004 Dec; 119(7):907-10. PubMed ID: 15620349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin-proteasome and the mitochondria-associated apoptotic pathways are sequentially downregulated during recovery after immobilization-induced muscle atrophy.
    Vazeille E; Codran A; Claustre A; Averous J; Listrat A; Béchet D; Taillandier D; Dardevet D; Attaix D; Combaret L
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1181-90. PubMed ID: 18812460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin and ubiquitin-like proteins as multifunctional signals.
    Welchman RL; Gordon C; Mayer RJ
    Nat Rev Mol Cell Biol; 2005 Aug; 6(8):599-609. PubMed ID: 16064136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms accelerating muscle atrophy in catabolic diseases.
    Mitch WE
    Trans Am Clin Climatol Assoc; 2000; 111():258-69; discussion 269-70. PubMed ID: 10881345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular signals activating muscle proteolysis in chronic kidney disease: a two-stage process.
    Du J; Hu Z; Mitch WE
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2147-55. PubMed ID: 15982920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of skeletal muscle atrophy.
    Ventadour S; Attaix D
    Curr Opin Rheumatol; 2006 Nov; 18(6):631-5. PubMed ID: 17053511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a common mechanism linking muscle wasting in various disease types?
    Tisdale MJ
    Curr Opin Support Palliat Care; 2007 Dec; 1(4):287-92. PubMed ID: 18685377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal-transduction networks and the regulation of muscle protein degradation.
    Szewczyk NJ; Jacobson LA
    Int J Biochem Cell Biol; 2005 Oct; 37(10):1997-2011. PubMed ID: 16125109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel aspects on the regulation of muscle wasting in sepsis.
    Hasselgren PO; Menconi MJ; Fareed MU; Yang H; Wei W; Evenson A
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2156-68. PubMed ID: 16125115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology.
    Schwartz AL; Ciechanover A
    Annu Rev Pharmacol Toxicol; 2009; 49():73-96. PubMed ID: 18834306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms stimulating protein degradation to cause muscle atrophy.
    Price SR; Mitch WE
    Curr Opin Clin Nutr Metab Care; 1998 Jan; 1(1):79-83. PubMed ID: 10565334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of protein degradation in skeletal muscle by a phorbol ester involves upregulation of the ubiquitin-proteasome proteolytic pathway.
    Wyke SM; Tisdale MJ
    Life Sci; 2006 May; 78(25):2898-910. PubMed ID: 16343552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rpn10 protects the proteasome from Dsk2.
    Walters KJ; Zhang N
    Mol Cell; 2008 Nov; 32(4):459-60. PubMed ID: 19026775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yeast Pth2 is a UBL domain-binding protein that participates in the ubiquitin-proteasome pathway.
    Ishii T; Funakoshi M; Kobayashi H
    EMBO J; 2006 Nov; 25(23):5492-503. PubMed ID: 17082762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight loss.
    Khal J; Hine AV; Fearon KC; Dejong CH; Tisdale MJ
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2196-206. PubMed ID: 16125116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolytic mechanisms, not malnutrition, cause loss of muscle mass in kidney failure.
    Mitch WE
    J Ren Nutr; 2006 Jul; 16(3):208-11. PubMed ID: 16825021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L.
    Schmidtke G; Kalveram B; Groettrup M
    FEBS Lett; 2009 Feb; 583(3):591-4. PubMed ID: 19166848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of muscle protein degradation in sepsis by eicosapentaenoic acid (EPA).
    Khal J; Tisdale MJ
    Biochem Biophys Res Commun; 2008 Oct; 375(2):238-40. PubMed ID: 18703014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.